BR112015005633A2 - composição farmacêutica tópica, processo para preparar uma composição farmacêutica tópica, método para prover ou facilitar a contracepção e método para tratar infecções retrovirais ou infecções bacterianas - Google Patents
composição farmacêutica tópica, processo para preparar uma composição farmacêutica tópica, método para prover ou facilitar a contracepção e método para tratar infecções retrovirais ou infecções bacterianasInfo
- Publication number
- BR112015005633A2 BR112015005633A2 BR112015005633A BR112015005633A BR112015005633A2 BR 112015005633 A2 BR112015005633 A2 BR 112015005633A2 BR 112015005633 A BR112015005633 A BR 112015005633A BR 112015005633 A BR112015005633 A BR 112015005633A BR 112015005633 A2 BR112015005633 A2 BR 112015005633A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- topical pharmaceutical
- infections
- preparing
- providing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2687MU2012 | 2012-09-14 | ||
PCT/GB2013/053001 WO2014041378A2 (en) | 2012-09-14 | 2013-11-14 | Topical pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015005633A2 true BR112015005633A2 (pt) | 2017-07-04 |
Family
ID=49725153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015005633A BR112015005633A2 (pt) | 2012-09-14 | 2013-11-14 | composição farmacêutica tópica, processo para preparar uma composição farmacêutica tópica, método para prover ou facilitar a contracepção e método para tratar infecções retrovirais ou infecções bacterianas |
Country Status (9)
Country | Link |
---|---|
US (1) | US20150246065A1 (pt) |
EP (1) | EP2968109A2 (pt) |
JP (1) | JP2015528490A (pt) |
AU (1) | AU2013316819A1 (pt) |
BR (1) | BR112015005633A2 (pt) |
CA (1) | CA2885037A1 (pt) |
MX (1) | MX2015003262A (pt) |
RU (1) | RU2015110470A (pt) |
WO (1) | WO2014041378A2 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010033726A2 (en) | 2008-09-17 | 2010-03-25 | The Brigham And Women's Hospital, Inc. | Drug delivery composition comprising a self-assembled gelator |
EP2618821A4 (en) | 2010-09-24 | 2014-08-13 | Brigham & Womens Hospital | NANOSTRUCTURED GELS FOR CONTROLLED RELEASE OF CAPSUED MEDIUM |
JP6352907B2 (ja) | 2012-06-13 | 2018-07-04 | イボフェム, インコーポレイテッド | 避妊殺菌剤の効果を増強するための組成物および方法 |
KR101669240B1 (ko) * | 2015-03-12 | 2016-10-25 | 아주대학교산학협력단 | 테노포비어 디소프록실 유리염기를 포함하는 정제 및 이의 제조방법 |
KR20170003063A (ko) * | 2015-06-30 | 2017-01-09 | 한미약품 주식회사 | 테노포비어 디소프록실 함유 경구용 고형제제 및 그 제조방법 |
EP3522879A4 (en) * | 2016-10-04 | 2020-06-03 | Evofem, Inc. | METHOD OF TREATING AND PREVENTING BACTERIAL VAGINOSIS |
US11020410B2 (en) | 2017-02-03 | 2021-06-01 | The Brigham And Women's Hospital, Inc. | Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof |
EP3621594A1 (en) | 2017-05-08 | 2020-03-18 | Alivio Therapeutics, Inc. | Formulation of nanostructured gels for increased agent loading and adhesion |
US10688043B1 (en) | 2018-03-20 | 2020-06-23 | Mario Elmen Tremblay | Personal lubricants comprising lambda-carrageenan |
US11744796B2 (en) * | 2018-03-20 | 2023-09-05 | Alternative Packaging Solutions, Llc | Personal lubricants comprising lambda-carrageenan |
EP3863602A1 (en) | 2018-10-11 | 2021-08-18 | Alivio Therapeutics, Inc. | Non-injectable hydrogel formulations for smart release |
WO2022076804A1 (en) * | 2020-10-08 | 2022-04-14 | North Carolina State University | Multifunctional contraceptive gel compositions and related methods of use |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2722689B1 (fr) | 1994-07-20 | 1996-10-04 | Fabre Pierre Dermo Cosmetique | Nouveau produit de combinaison comprenant un agent antifongique et du crotamiton comme potentialisateur de l'activite de l'agent antifongique, et compositions dermatologiques et/ou cosmetiques le comprenant |
FR2740685B1 (fr) | 1995-11-08 | 1998-01-23 | Pf Medicament | Composition pharmaceutique topique moussante pour le traitement des dermatoses, induites par pityrosporum ovale |
DE19781197D2 (de) * | 1996-10-31 | 2000-07-13 | Notax Holding Ges M B H Wien | Verwendung von Polyäthylenglykol-9-Nonylphenyläther |
ITMI20010913A1 (it) * | 2001-05-04 | 2002-11-04 | Univ Pavia | Composizioni a rilascio controllato di acido lattico a livello vaginale |
WO2004105662A1 (en) | 2003-05-23 | 2004-12-09 | Program For Appropriate Technology In Health | Microbicidal compositions and methods of use |
UA93354C2 (ru) | 2004-07-09 | 2011-02-10 | Гилиад Сайенсиз, Инк. | Местный противовирусный препарат |
BRPI0907317A2 (pt) * | 2008-04-16 | 2019-08-27 | Cipla Ltd | composição farmacêutica e método para fabricar uma composição farmacêutica tópica em gel, espuma e em spray |
-
2013
- 2013-11-14 WO PCT/GB2013/053001 patent/WO2014041378A2/en active Application Filing
- 2013-11-14 MX MX2015003262A patent/MX2015003262A/es unknown
- 2013-11-14 BR BR112015005633A patent/BR112015005633A2/pt not_active IP Right Cessation
- 2013-11-14 RU RU2015110470A patent/RU2015110470A/ru not_active Application Discontinuation
- 2013-11-14 AU AU2013316819A patent/AU2013316819A1/en not_active Abandoned
- 2013-11-14 CA CA2885037A patent/CA2885037A1/en not_active Abandoned
- 2013-11-14 JP JP2015531651A patent/JP2015528490A/ja active Pending
- 2013-11-14 EP EP13802088.8A patent/EP2968109A2/en not_active Withdrawn
- 2013-11-14 US US14/427,906 patent/US20150246065A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2014041378A3 (en) | 2014-05-30 |
RU2015110470A (ru) | 2016-11-10 |
WO2014041378A2 (en) | 2014-03-20 |
EP2968109A2 (en) | 2016-01-20 |
JP2015528490A (ja) | 2015-09-28 |
AU2013316819A1 (en) | 2015-04-02 |
US20150246065A1 (en) | 2015-09-03 |
CA2885037A1 (en) | 2014-03-20 |
MX2015003262A (es) | 2016-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015005633A2 (pt) | composição farmacêutica tópica, processo para preparar uma composição farmacêutica tópica, método para prover ou facilitar a contracepção e método para tratar infecções retrovirais ou infecções bacterianas | |
BR112014003296A2 (pt) | composto, composição farmacêutica, processo para a preparação de uma composição farmacêutica, método para o tratamento de uma doença ou distúrbio, conjunto para o tratamento de uma condição mediada pela quinase pim e utilização do composto | |
BR112015001098A2 (pt) | composto, composição farmacêutica e método para o tratamento de uma condição de doença. | |
BR112014003681A8 (pt) | composto, composição farmacêutica, produto de combinação farmacêutica, uso de um composto, e, método para tratar doenças ou condições | |
BR112015031475A2 (pt) | composto, composição farmacêutica, método para tratamento de uma doença ou condição, kit, e, uso de composto. | |
BR112015003397A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente. | |
BR112015003332A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
BR112014030069A2 (pt) | processo para purificar uma composição de ácido furan, e, composição de ácido furan | |
BR112015003398A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
BR112012028530A2 (pt) | composto, composição farmacêutica e seu processo de preparação e método para o tratamento de uma doença ou transtorno | |
BR112014002621A2 (pt) | anticorpo, composição farmacêutica, combinação farmacêutica, dna e método de tratamento | |
BR112014028755A2 (pt) | composição de argamassa de poliuretano, processo para preparação da composição de argamassa de poliuretano, e, uso de uma composição de argamassa de poliuretano. | |
BR112014010179A8 (pt) | composto, composição farmacêutica, uso de um composto, e, método para a profilaxia ou tratamento de um estado ou condição | |
BR112014012666A8 (pt) | composição de revestimento marcada, artigo, método para preparar o artigo e método para autenticar uma composição | |
BR112013030163A2 (pt) | composto, uso cosmético de pelo menos um composto, composição farmacêutica ou cosmética e processo para preparar um composto. | |
BR112012026843A2 (pt) | composição, composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição e método para tratamento de hiv | |
BR112014031896A2 (pt) | composto, composição farmacêutica, e, método para o tratamento de um distúrbio | |
BR112013010738A2 (pt) | composto, composição farmacêutica, e, método para tratar uma infecção viral | |
EA202190774A3 (ru) | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения | |
SG11201504791VA (en) | Pharmaceutical composition for treating headache, and preparation method thereof | |
BR112013025340A2 (pt) | composto, composição farmacêutica, método para tratar uma doença ou distúrbio relacionado com pi3k num indivíduo necessitado, método para tratar doença mediada por hdac e método para tratar tanto doenças mediadas por pi3k como por hdac | |
BR112014031899A8 (pt) | composto, composição farmacêutica, e, método para tratamento de um distúrbio | |
BR112014025339A8 (pt) | método para tratamento ou prevenção ou redução de infecção do virus influenza e composição farmacêutica para o mesmo. | |
BR112014026564A2 (pt) | formulação, uso de uma formulação, e, processo para a preparação de uma formulação | |
BR112015006955A2 (pt) | composição para a higiene bucal, método para aprimoramento e processo para a fabricação da composição. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |